featured
Transcatheter ViV Outcomes Surpass Those With Redo SAVR for Failed Biological Prosthesis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Initial Orientation of Transcatheter Heart Valves Impact Final Orientation and Overlap With Coronary Arteries
- Coronary Access After TAVR
- Coronary Access After TAVR With a Self-Expanding Bioprosthesis
- Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients
- Coronary Protection to Prevent Coronary Obstruction During TAVR
- Chimney Stenting for Coronary Occlusion During TAVR
- Quantitative Assessment of Acute Regurgitation Following Transcatheter Aortic Valve Replacement
- Navigating the "Optimal Implantation Depth" With a Self-Expandable TAVR Device
Disclosure statements are available on the authors' profiles:
JACC: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Transcatheter ViV Versus Redo Surgical AVR for the Management of Failed Biological Prosthesis: Early and Late Outcomes in a Propensity-Matched Cohort
JACC Cardiovasc Interv 2020 Mar 23;13(6)765-774, DY Tam, C Dharma, RV Rocha, M Ouzounian, HC Wijeysundera, PC Austin, J Chikwe, M Gaudino, SE FremesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.